CIS Offers Insight on Proposed Sunshine Rule

Top Quote Clarification regarding CMS' proposed rule on the "Physician Payment Sunshine" provisions of the Affordable Care Act will be addressed in a complimentary CIS webinar on Thursday, January 5, 2012 at 2:00pm EST. End Quote
  • Philadelphia, PA-NJ (1888PressRelease) December 20, 2011 - Compliance Implementation Services (CIS), a leading life sciences consulting firm, announced today that it will host a complimentary webinar to provide a more detailed overview of the CMS proposed rule on the "Physician Payment Sunshine" provisions of the Affordable Care Act. CIS' subject matter experts will provide additional insights and points of consideration on Thursday, January 5, 2012 from 2:00 to 3:15pm EST.

    The webinar will address the many changes and clarifications resulting from the new rule, including the following:
    - The delay in data collection;
    - The clarifying definitions of terms like "applicable GPO", "applicable manufacturer", "covered drug", and "teaching hospital";
    - Overview of Proposed Reporting Requirements
    - Payments & Other Transfers of Value
    - Physician Ownership & Investment Interests
    - Data review by manufacturers, physicians, and teaching hospitals prior to public posting;
    - Enforcement of penalties as outlined in the law;
    - Preemption of state or local laws.

    To register and submit questions in advance, visit CIS' website, choose Resources and scroll to Webinars, then click on Federal Sunshine Proposed Rule Review. Recent articles on CIS' Pharma Compliance Blog provide supplemental background information in preparation of the webinar. A link to the proposed rule will be available on the Federal Register Monday, December 19th, 21 CFR parts 402 and 403.

    About Compliance Implementation Services (CIS) Compliance Implementation Services (CIS) is a life sciences consulting firm specializing in compliance strategies for pharmaceutical, biotech, and medical device companies, from global clinical research and development, through manufacturing, U.S. commercial compliance, and government programs. CIS provides its clients with a deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions to establish a "Culture of Compliance" that is both meaningful and sustainable.

    Pharma Compliance Insight (PCI) is a series of webinars presented by CIS' industry experts providing insight around navigating the regulatory landscape.

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information